News Room
Biotech stocks set for a rebound in 2024, analysts say
A more favorable interest-rate outlook, an uptick in deals, and innovations in key areas like cancer and immunology are setting…
Rejoice that Santa Claus gives prime delivery to everyone
Stay informed with free updatesSimply sign up to the Retail & Consumer industry myFT Digest -- delivered directly to your…
Vans maker, Crocs and Under Armour stocks dive on back of Nike shares’ plunge
Shares of Nike Inc. NKE, -11.83% tumbled 10.4% in morning trading Friday, enough to pace the S&P 500’s SPX, +0.17%…
‘We’re not celebrating’: Christmas called off in Bethlehem as Gaza war rages
The ceremonial lighting of the Christmas tree in Bethlehem was expected to be so popular this year that the city…
AlloVir’s stock suffers record plunge toward a record low after trials on T cell therapy
Shares of AlloVir Inc. ALVR, -67.15% plummeted 66.6% toward their first-ever close below $1 on heavy volume in afternoon trading…
Blackstone loads up on European real estate investments
Unlock the Editor’s Digest for freeRoula Khalaf, Editor of the FT, selects her favourite stories in this weekly newsletter.Blackstone invested…
OpenAI discussing new funding round that could give it $100 billion valuation: report
OpenAI, the influential artificial-intelligence startup behind ChatGPT, is in talks to raise new funding that could give it a valuation…
Tony Blair think-tank revenues hit $140mn as governments pay for advice
Tony Blair has revealed that his institute is on course to make $140mn in annual revenues and provide advice to…